Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Winkler, Frank

  • Google
  • 3
  • 37
  • 31

University Hospital Heidelberg

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (3/3 displayed)

  • 2024Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis13citations
  • 2018Fabrication and replication of re-entrant structures by nanoimprint lithography methods9citations
  • 2018Fabrication and replication of re-entrant structures by nanoimprint lithography methods9citations

Places of action

Chart of shared publication
Kehagias, Nikolaos
1 / 7 shared
Sotomayor Torres, Clivia M.
1 / 22 shared
Guttmann, Markus
2 / 11 shared
Francone, Achille
2 / 9 shared
Fernãndez Estãvez, Ariadna
1 / 2 shared
Fernández, Ariadna
1 / 2 shared
Sotomayor Torres, C. M.
1 / 13 shared
Kehagias, N.
1 / 7 shared
Chart of publication period
2024
2018

Co-Authors (by relevance)

  • Kehagias, Nikolaos
  • Sotomayor Torres, Clivia M.
  • Guttmann, Markus
  • Francone, Achille
  • Fernãndez Estãvez, Ariadna
  • Fernández, Ariadna
  • Sotomayor Torres, C. M.
  • Kehagias, N.
OrganizationsLocationPeople

article

Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis

  • Yu, Wenxi
  • Misquitta, Josette
  • Rominyi, Ola
  • Carruthers, Ross
  • Derby, Sarah J.
  • Vanderlinden, Aurelie
  • Strathdee, Karen E.
  • Koessinger, Anna
  • Mclay, Kathy
  • Alsharif, Sama
  • Solecki, Gergely
  • Chalmers, Anthony J.
  • Mcghee, Ewan
  • Heiland, Dieter Henrik
  • Gilmour, Lesley
  • Tian, Yuling
  • Norman, Jim
  • Winkler, Frank
  • Lemgruber, Leandro
  • Birch, Joanna L.
  • Collis, Spencer J.
  • Dutton, Louise
  • Jackson, Mark
  • Stevenson, Katrina
  • Clarke, Cassie J.
  • Olson, Michael
  • Mcgarrity-Cottrell, Connor L.
  • Inman, Gareth J.
  • Thomason, Peter
  • Carlin, Leo M.
Abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Glioblastomas have highly infiltrative growth patterns that contribute to recurrence and poor survival. Despite infiltration being a critical therapeutic target, no clinically useful therapies exist that counter glioblastoma invasion. Here, we report that inhibition of ataxia telangiectasia and Rad 3 related kinase (ATR) reduces invasion of glioblastoma cells through dysregulation of cytoskeletal networks and subsequent integrin trafficking.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Glioblastoma motility and invasion were assessed in vitro and in vivo in response to ATR inhibition (ATRi) and ATR overexpression using time-lapse microscopy, two orthotopic glioblastoma models, and intravital imaging. Disruption to cytoskeleton networks and endocytic processing were investigated via high-throughput, super-resolution and intravital imaging.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>High ATR expression was associated with significantly poorer survival in clinical datasets while histological, protein expression, and spatial transcriptomics using glioblastoma tumor specimens revealed higher ATR expression at infiltrative margins. Pharmacological inhibition with two different compounds and RNAi targeting of ATR opposed the invasion of glioblastoma, whereas overexpression of ATR drove migration. Subsequent investigation revealed that cytoskeletal dysregulation reduced macropinocytotic internalization of integrins at growth-cone-like structures, resulting in a tumor microtube retraction defect. The biological relevance and translational potential of these findings were confirmed using two orthotopic in vivo models of glioblastoma and intravital imaging.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>We demonstrate a novel role for ATR in determining invasion in glioblastoma cells and propose that pharmacological targeting of ATR could have far-reaching clinical benefits beyond radiosensitization.</jats:p></jats:sec>

Topics
  • compound
  • defect
  • size-exclusion chromatography
  • microscopy